FXN and cardiomyopathy: In a conditional mouse model with complete Fxn deletion in cardiac muscle, intravenous administration of adeno-associated virus (AAV) rh10 vector expressing human FXN intravenously prevented occurrence of cardiomyopathy or completely restored heart function [28].